Astria Therapeutics Stock (NASDAQ: ATXS) stock price, news, charts, stock research, profile.
Open | $11.62 |
Close | - |
Volume / Avg. | 57.42K / 595.99K |
Day Range | 11.27 - 11.86 |
52 Wk Range | 4.26 - 16.90 |
Market Cap | $650.17M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 74 |
Short Interest | 8.03% |
Days to Cover | 7.64 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Astria Therapeutics (NASDAQ:ATXS) through any online brokerage.
Other companies in Astria Therapeutics’s space includes: KalVista Pharma (NASDAQ:KALV), Celcuity (NASDAQ:CELC), Larimar Therapeutics (NASDAQ:LRMR), Replimune Group (NASDAQ:REPL) and PepGen (NASDAQ:PEPG).
There is no analysis for Astria Therapeutics.
Astria Therapeutics has a consensus price target of $21.60.
The stock price for Astria Therapeutics (NASDAQ: ATXS) is $11.665 last updated Today at July 17, 2024 at 10:18 AM EDT.
There are no upcoming dividends for Astria Therapeutics.
Astria Therapeutics’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for Astria Therapeutics.
Astria Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.